Long-term SGLT2 inhibitor therapy improves myocardial strain and diastolic function in HFpEF: a retrospective study linking functional recovery to reduced myocardial fibrosis - Top-Institutions - MDSpire

SGLT2 Inhibitor Therapy Enhances Myocardial Strain and Diastolic Function in Patients with HFpEF: A Retrospective Analysis Linking Functional Improvement to Decreased Myocardial Fibrosis

  • By

  • Xiaojin Xu

  • Hongyang Liu

  • Runyang Chen

  • July 21, 2026

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Brigham and Women's Hospital
    Brigham and Women's Hospital

    Boston, Massachusetts

    Key Differentiators

    • Cardiology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Cardiology

  • #3

    University of California, Davis
    University of California, Davis

    Davis, California

    Key Differentiators

    • Cardiology

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Cardiology

  • #5

    University of Michigan
    University of Michigan

    Ann Arbor, Michigan

    Key Differentiators

    • Cardiology

Original Source(s)

Long-term SGLT2 inhibitor therapy improves myocardial strain and diastolic function in HFpEF: a retrospective study linking functional recovery to reduced myocardial fibrosis

  • by Xiaojin Xu, Hongyang Liu, Runyang Chen

  • July 21, 2026

Related Content

The unified cardiometabolic disease continuum: mechanistic stages of a single pathophysiological process

Charlson comorbidity Index for descriptive risk stratification of long-term All-cause mortality in elderly patients with acute myocardial infarction: a retrospective cohort study

Psychometric validation of the Chinese Warwick–Edinburgh mental well-being scale in patients with heart failure or myocardial infarction: evidence from classical test theory and item response theory